Sharekhan

Alpa Laboratories Ltd

Thu 13/03/2025,15:43:59 | NSE : ALPA

₹ 106.653.13 (3.02%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 104.30

Previous Close

₹ 103.52

Volume

29615

Mkt Cap ( Rs. Cr)

₹224.40

High

₹ 108.59

Low

₹ 104.30

52 Week High

₹ 144.50

52 Week Low

₹ 69.90

Book Value Per Share

₹ 78.24

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Alpa Laboratories Ltd

Your Vote -

Buy

68.75%

Hold

12.50%

Sell

18.75%

68.75%

32 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Alpa Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Alpa Laboratories Lt - Clarification - Financial Results

    6 Mar 2025, 8:17PM The Exchange has sought clarification from Alpa Laboratories Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (List
  • Alpa Laboratories Lt - Integrated Filing- Financial

    17 Feb 2025, 2:37PM Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024
  • Alpa Laboratories Lt - Integrated Filing (Financial)

    17 Feb 2025, 2:48PM Integrated Filing (Financial) for the Quarter and nine months ended December 31, 2024
  • Alpa Laboratories Lt - General Updates

    14 Feb 2025, 5:41PM Alpa Laboratories Limited has informed the Exchange about General Updates
  • Alpa Laboratories Lt - Change In Designation Of Mr. Vitthal Kothana (DIN- 09489318) From Non-Executive Director To Executive

    14 Feb 2025, 5:30PM Change in designation of Mr. Vitthal Kothana (DIN- 09489318) from Non-Executive Director to Executive Director.
  • Alpa Laboratories Lt - Financial Result Updates

    14 Feb 2025, 3:00PM Alpa Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Alpa Laboratories Lt - Appointment of Company Secretary and Compliance Officer

    13 Feb 2025, 7:42PM Appointment of MS. Srashti Chopra as a company secretary and compliance officer
  • Alpa Laboratories Lt - Updates

    13 Feb 2025, 7:40PM Alpa Laboratories Limited has informed the Exchange regarding ''.Appointment of MS. Srashti Chopra as a company secretary and compliance officer
  • Alpa Laboratories Lt - Outcome of Board Meeting

    13 Feb 2025, 7:33PM Alpa Laboratories Limited has informed the Exchange regarding Board meeting held on February 13, 2025.
  • Alpa Laboratories Lt Q3 net profit jumps 96.25% at Rs 8.89 cr

    13 Feb 2025, 7:20PM The company reported standalone net profit of Rs 8.89 crore for the quarter ended December 31, 2024 as compared to Rs 4.53 crore in the same period la
  • Alpa Laboratories Lt - Financial Results For The Quarter Ended December, 2024

    13 Feb 2025, 7:17PM Financial Results for the Quarter ended December, 2024
  • Alpa Laboratories Lt - Disclosure of material issue

    7 Feb 2025, 3:29PM Alpa Laboratories Limited has informed regarding Disclosure of material issue
  • Alpa Laboratories Lt - Announcement under Regulation 30 (LODR)-Acquisition

    7 Feb 2025, 3:24PM Acquisition of Land at Pithampur.
  • Alpa Laboratories Lt - Board Meeting Intimation

    3 Feb 2025, 5:17PM ALPA LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2025 to consider and approve the Quarterly Unaudited Fina
  • Alpa Laboratories Lt - Board Meeting Intimation for To Approve The Standalone And Consolidated Unaudited Financial Results Fo

    3 Feb 2025, 5:14PM ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider a
  • Alpa Laboratories Lt has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    20 Jan 2025, 3:10PM As of December 2024, 57.29% is owned by Indian Promoters and 42.71% by Public. <p align=justify> Top five Promoters holding highest number of shares o
  • Alpa Laboratories Lt - Trading Window

    30 Dec 2024, 5:15PM Alpa Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations
  • Alpa Laboratories Lt - Trading Window-XBRL

    30 Dec 2024, 4:11PM Alpa Laboratories Limited has informed the Exchange about Closure of Trading Window

Key fundamentals

Evaluate the intrinsic value of Alpa Laboratories Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 167.2191 147.1215 137.4871 117.5297 110.4216
Liabilities 167.2191 147.1215 137.4871 117.5297 110.4216
Equity 21.0406 21.0406 21.0406 21.0406 21.0406
Gross Profit 8.1447 8.0761 10.6864 7.7085 3.452
Net Profit 16.7777 12.6243 14.1258 7.2644 4.0781
Cash From Operating Activities 3.6991 8.8196 2.2041 -1.4511 17.6568
NPM(%) 15.42 13.58 12.58 7.44 4.74
Revenue 108.7391 92.9552 112.2664 97.554 85.9691
Expenses 100.5944 84.8791 101.58 89.8455 82.5171
ROE(%) 10.19 7.66 8.58 4.41 2.47

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Alpa Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 808.20 -1.14 11.41 60.58 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 57.06 -0.77 237.75 220.75 14.01 0.88
Vaishali Pharma Ltd 12.12 -5.90 606.00 113.78 2.31 0.00
Astec Lifesciences Ltd 653.90 -5.55 0.00 208.15 -239.30 0.00

Company Info

Mr. Purushottam R. Patel, Mr. M.S. Chawla and Mr. Pravin C. Shah, partners of M/s Alpa Laboratories, which was formed in the year 1967, incorporated a private limited company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In the year 1998, Alpa Laboratories Private Limited was converted into a public limited company with effect from September 3, 1998 with the name of "Alpa Laboratories Limited". In the year 1997, we initiated setting of a new manufacturing unit at 33/2, Pigdamber, A.B. Road, Rau, District Indore, Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. We manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark "Alpa" which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. We also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, we also undertake contract manufacturing of a large variety of pharmaceuticals. We manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. We have an established product-marketing network covering both metro and mini metro cities, which enable us to reach our existing and potential customers through our network of distributors and dealers spread across the country. For the purpose of marketing the various products, our Company's business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. HISTORY AND MAJOR EVENTS 1988 Incorporation of Alpa Laboratories Private Limited 1997 Commenced setting up of manufacturing facility at Pigdamber, Indore 1998 Conversion to Alpa Laboratories Limited, a public limited company 1999 Start of commercial production 2001 WHO GMP Certification for its manufacturing facilities Entered into an agreement for Contract manufacturing at its newly constructed facility, with Plethico Pharmaceuticals Ltd., a Pharmaceutical company, for manufacturing its various range of products. The manufacturing facilities at Pigdamber were certified as WHO GMP compliant by SGS-ICS Belgium for the period 2001-02. 2003 Certified ISO 9001: 2000* The manufacturing facility at Pigdamber was approved by the Director General of Quality Assurance (DGQA), India thereby opening its doors for participating in Tenders for supplies to defence institutions** Started export of its Veterinary products and registered its 7 veterinary products in Sudan 2006 Started participation in international tenders for export in addition to domestic marketing abroad and won a major tender from CMS, Sudan. Launched Veterinary Division with a new face and ethical promotion of its Veterinary products launched in 5 states in the year 2006. Launched Ethical division for its human products * Expired on May 14, 2006 ** Expired on January 22, 2006. This certificate is not required now as our revenue have crossed Rs 2000.00 lakhs as per DGQA norms. 2007 -Alpa Laboratories ties up with Vhermann Pharmaceutical Inc, Philippines for distribution of its products. 2010 - The Company has recommended dividend of 10%. 2014 - Ms. Monali Patel, Member of The Institute of Company Secretaries of India (ICSI) has been appointed as the Company Secretary and Compliance Officer. - Alpa Laboratories has sold its Unit-II ("Undertaking) situated at Sector III, Pithampur, Dhar (M.P.) as a going concern on a slump sale basis to Ipca Laboratories Limited. 2015 -Alpa Laboratories Ltd has formed a wholly owned subsidiary under the name and style of Norfolk Mercantile Private Ltd.

Mr. Purushottam R. Patel, Mr. M.S. Chawla and Mr. Pravin C. Shah, partners of M/s Alpa Laboratories, which was formed in the year 1967, incorporated a private limited company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In the year 1998, Alpa Laboratories Private Limited was converted into a public limited company with effect from September 3, 1998 with the name of "Alpa Laboratories Limited". In the year 1997, we initiated setting of a new manufacturing unit at 33/2, Pigdamber, A.B. Road, Rau, District Indore, Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. We manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark "Alpa" which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. We also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, we also undertake contract manufacturing of a large variety of pharmaceuticals. We manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. We have an established product-marketing network covering both metro and mini metro cities, which enable us to reach our existing and potential customers through our network of distributors and dealers spread across the country. For the purpose of marketing the various products, our Company's business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. HISTORY AND MAJOR EVENTS 1988 Incorporation of Alpa Laboratories Private Limited 1997 Commenced setting up of manufacturing facility at Pigdamber, Indore 1998 Conversion to Alpa Laboratories Limited, a public limited company 1999 Start of commercial production 2001 WHO GMP Certification for its manufacturing facilities Entered into an agreement for Contract manufacturing at its newly constructed facility, with Plethico Pharmaceuticals Ltd., a Pharmaceutical company, for manufacturing its various range of products. The manufacturing facilities at Pigdamber were certified as WHO GMP compliant by SGS-ICS Belgium for the period 2001-02. 2003 Certified ISO 9001: 2000* The manufacturing facility at Pigdamber was approved by the Director General of Quality Assurance (DGQA), India thereby opening its doors for participating in Tenders for supplies to defence institutions** Started export of its Veterinary products and registered its 7 veterinary products in Sudan 2006 Started participation in international tenders for export in addition to domestic marketing abroad and won a major tender from CMS, Sudan. Launched Veterinary Division with a new face and ethical promotion of its Veterinary products launched in 5 states in the year 2006. Launched Ethical division for its human products * Expired on May 14, 2006 ** Expired on January 22, 2006. This certificate is not required now as our revenue have crossed Rs 2000.00 lakhs as per DGQA norms. 2007 -Alpa Laboratories ties up with Vhermann Pharmaceutical Inc, Philippines for distribution of its products. 2010 - The Company has recommended dividend of 10%. 2014 - Ms. Monali Patel, Member of The Institute of Company Secretaries of India (ICSI) has been appointed as the Company Secretary and Compliance Officer. - Alpa Laboratories has sold its Unit-II ("Undertaking) situated at Sector III, Pithampur, Dhar (M.P.) as a going concern on a slump sale basis to Ipca Laboratories Limited. 2015 -Alpa Laboratories Ltd has formed a wholly owned subsidiary under the name and style of Norfolk Mercantile Private Ltd.

Read More

Parent Organisation

Alpa Laboratories Ltd.

Founded

18/03/1988

Managing Director

Mr.Paresh Chawla

NSE Symbol

ALPAEQ

FAQ

The current price of Alpa Laboratories Ltd is ₹ 106.65.

The 52-week high for Alpa Laboratories Ltd is ₹ 108.59 and the 52-week low is ₹ 104.30.

The market capitalization of Alpa Laboratories Ltd is currently ₹ 224.40. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Alpa Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Alpa Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Alpa Laboratories Ltd shares.

The CEO of Alpa Laboratories Ltd is Mr.Paresh Chawla, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT